Daniel Guimarães Tiezzi
11PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Dec 30, 2025
The HER2MtGx Metagene Score as a Reliable Tool to Select HER2 Breast Cancer Patients for Neoadjuvant Targeted Therapy.Daniel Guimarães Tiezzi, Isabela Panzeri Carlotti Buzatto, Willian Abraham da Silveira
|Oct 09, 2024
Potential biomarkers as a predictive factor of response to primary chemotherapy in breast cancer patients.F O Buono, R D S Pugliese, W A da Silveira
|Aug 23, 2024
Real-world data on adjuvant capecitabine after standard neoadjuvant chemotherapy for triple negative breast cancer.Maria Fernanda Imperio Pereira, Isabela Panzeri Carlotti Buzatto, Hélio Humberto Angotti Carrara
|Jul 13, 2024
Machine learning can reliably predict malignancy of breast lesions based on clinical and ultrasonographic features.I P C Buzatto, S A Recife, L Miguel
|Feb 21, 2024
Converging and evolving immuno-genomic routes toward immune escape in breast cancer.Juan Blanco-Heredia, Carla Anjos Souza, Juan L Trincado
|Nov 09, 2022
Validation of the online PREDICT tool in a cohort of early breast cancer in Brazil.M B Magário, R R Dos Santos, L A Teixeira
Pageof 2
Frequent Collaborators
5 joint publications
Jurandyr Moreira de Andrade
4 joint publications
Francisco Jose Candido Dos Reis
3 joint publications
Leticia De Mattos-Arruda
2 joint publications
Leonardo Fleury Orlandini
2 joint publications
F F Pimentel
2 joint publications
Omero Benedito Poli Neto
2 joint publications
H H A Carrara
2 joint publications
Fabiana de Oliveira Buono
2 joint publications
Samuel Gonçalves-Ribeiro
1 joint publications
M B Magário
